Conference Brochure

Inside
Sponsors and exhibitors
P. 3
Complete program details
P. 4
2015 PIAA award winners
P. 4 & P. 7
Don’t forget your wireless device
P. 5
30TH anniversary of the Data Sharing Project
P. 8
2015 Medical Liability Conference
Dear PIAA members and colleagues:
We are so pleased that you could join us here in Las Vegas, for what promises to be an
exciting and informative conference. We’ve got a content-rich schedule lined up for you.
You’ll hear from high-profile speakers, listen to panels with decades of experience in medical professional liability (MPL), and learn some surprising perspectives on what’s happening
in our industry. You can get caught up with colleagues and make some new connections
with the professionals who share your passion for MPL.
PIAA members and stakeholders from around the world are joining us in Las Vegas. While
we each bring our unique background and experiences to the conference, we can agree on
several foundational principles. We appreciate the critical importance of MPL coverage in
our healthcare system. We believe in the relentless pursuit of patient safety. We are dedicated to the quality delivery of healthcare.
Over the next few days, you will learn about the current status of MPL in the U.S. and
around the world. You’ll gain important insights on the multitude of issues you need to think
about every day. We all realize that the healthcare system is dynamic. Here, you’ll learn how
to work best within this evolving system, and transform the new knowledge and insights you
gain into action.
PIAA developed this event with a focus on the multiple professions that contribute to MPL,
as well as on the different levels of experience that various attendees bring to the conference. Whether you’re just starting to explore the knowledge and issues that matter in MPL,
or are already a seasoned expert in them, we encourage you to learn all you can from the
rich diversity of sessions. This is your opportunity to speak with the acknowledged experts
in the MPL business–so ask all your questions. But don’t forget to set aside some time for
the exciting social events we have planned.
Cordially,
2
Gloria H. Everett
Tamara D. Huffman
Brian K. Atchinson
Chair, PIAA
Chair, 2015 PIAA Medical
Liability Conference
President & CEO, PIAA
Sponsors and Exhibitors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Additional Sponsors
Lanyards
Map
F Guy
F A.M.
Carpenter
WiFi/Mobile App
F The
Doctors Company
Conference Folder
F Constellation
Refreshment Breaks
Best Company
Chair’s Reception for New
Attendees & Guests
F The
Mutual Risk Retention Group, Inc.
Hotel Key Cards
F Medical
Interactive Community
F COPIC
Popcorn Cart
F Freeman
Enterprises
Attendee Gift
F Cincom
Exhibitors
F Bottomline
Technologies
Booth #30
F GR-NEAM
Booth #31
F Cincom
PFS
Booth #20
Booth #18
F Conning
F Constellation
F Saslow
F Johnson
F Sedgwick
F MedFax
Booth #8
Booth #29
Technology, Inc.
Booth #s 9 & 10
Medical Graphics
Booth #5
F Imperial
Lambert LLP
Booth #16
Booth #12
F S&A
Booth #13
F SUMIT
Holdings–TRA
Booth #15
F Delphi
F Medical
F Summit
F ECRI
F Oliver
F Swiss
F ELM
F Perinatal
F TriNet
F Pinnacle
F Vermont
F Prime
F VisualDx
Institute
Booth #32
Wyman Actuarial Consulting
Booth #14
Exchange
Booth #2
F Empathetics,
Inc.
Booth #1
F FIRST
Interactive Community
Booth #s 23 & 24
Lufkin & Buggy LLP
Booth #22
Insurance Funding Corp.
Booth #27
Quality Foundation
Booth #11
Actuarial Resources, Inc.
Booth #19
Advisors, Inc.
Booth #17
Reinsurance Services, Inc.
Booth #25
Re
Booth #21
HR Corporation
Booth #3
Captive Insurance Association
Booth #28
Booth #26
As of 4/1/15
3
Conference Agenda
Wednesday, May 13, 2015
4:00–7:00 p.m. Platinum Sponsor Welcome Reception
Florentine Ballroom/Promenade Level
Registration and Exhibit Area Open
Registered Attendees and Paid Guests Welcome
6:30–7:30 p.m. Chair’s Reception for New
Attendees & Guests
Messina/Promenade Level
(By Invitation Only)
Thursday, May 14, 2015
7:00–8:30 a.m.
in Exhibit Area
Silver Sponsor Breakfast
Florentine Ballroom/Promenade Level
Registered Attendees and Paid Guests Welcome
7:00–8:15 a.m.
PIAA PAC Breakfast
Pisa and Palermo/Promenade Level
(By Invitation Only)
10:15–10:45 a.m.
Refreshment Break in Exhibit Area
Florentine Ballroom/Promenade Level
8:30–9:15 a.m. Welcome and Opening Remarks
Fellows Recognition Leadership Awards PIAA
Award of Excellence in Honor of Peter Sweetland
10:45 a.m.–Noon
Roman Ballroom/Promenade Level
Moderator:
F Peter Whitted, MD, JD, Director, COPIC; Ophthalmologist,
Midwest Eye Care, P.C.
Gloria H. Everett, Chair, PIAA
F Brian K. Atchinson, President & CEO, PIAA
F Tamara D. Huffman, Chair, 2015 Medical Liability Conference
F
Congratulations to the 2015
PIAA Award Winners!
PIAA Award of Excellence in
Honor of Peter Sweetland
F Victor
Victor T. Adamo
T. Adamo, JD, CPCU
Leadership Awards
F Mary-Lou A. Misrahy, ARM
CEO/COO Section
F William
C. Passolt
Leadership Camp Section
9:15–10:15 a.m.
Keynote Speaker
Roman Ballroom/Promenade Level
Seeing Beyond Reform: A Leadership Guide
to the Emerging New Normal in Healthcare
F James E. Orlikoff, President, Orlikoff &
James E. Orlikoff
Associates, Inc.; National Advisor on Governance and Leadership to the American Hospital Association
4
The “new normal” of healthcare is here! In today’s landscape,
we see depressed hospital volumes and margins, declining
reimbursement, mergers and new affiliations creating supersystems, innovations like ACOs emerging daily, and much
more. The challenges facing both leaders and individual healthcare professionals are daunting—but they can be overcome.
First, leaders need to recognize that the changes in healthcare
really are transformational—not just transactional. Leaders
need to position their organizations so they become something
radically different. They need to work on the system, not just
in it. And they need to work on themselves as well, to leverage leadership best practices at all levels. In this presentation,
Mr. Orlikoff, author of the award-winning book, “Board Work:
Governing Health Care Organizations,” and the primary author
of “Malpractice Prevention and Liability Control for Hospitals,”
will discuss the macro forces driving revolutionary change in
healthcare, and their probable repercussions. He will also suggest approaches to effective transformative leadership, based
on more than 25 years’ experience in consulting for healthcare
systems in six countries.
Concurrent Session I
Roman Ballroom/Promenade Level
Legal Implications of Genetic Testing/Therapy
Panel:
F Donna A. Messner, PhD, Vice President and Senior Research
Director, Lead, GPC-USA Oncology Consortium, Center for
Medical Technology Policy
F Gary Marchant, PhD, JD, Faculty Director, Center for Law,
Science & Innovation, Sandra Day O’Connor College of Law,
Arizona State University
F Joseph Sanders, JD, PhD, A.A. White Professor of Law, University of Houston Law Center
Genetic testing has a key place in the recent trend toward
personalized medicine, helping patients and their physicians
learn whether they have a predisposition to certain medical
conditions, including cancer, as well as providing guidance for
genomically targeted therapies for certain diseases. Several
companies are marketing genetic testing materials, and the
wider availability of these tests appeals to those patients who
would like to know what their future may hold. However, some
commentators have noted that the ability to identify genetic
mutations has outpaced our understanding of their potential
consequences. Another avenue of concern are payer policies
on reimbursement for genetic testing—what does it take to get
Reminder: Bring your electronic
device of choice—laptop, tablet, or
smartphone—so you can take full
advantage of the WiFi connection
and PIAA’s mobile app.
this testing covered and what are the costs if health insurers
deny coverage for the testing. In light of this environment, will
genetic testing be linked with additional liability for physicians? Should genetic testing—multi-panel or specific-gene
testing—become one element in the standard of care for
certain patients? What disclosure duties come with genetic test
information that may have no significance when other important related findings are not present, i.e., there are “variants
of unknown significance?” How do courts of law look upon
genetic testing data? All important elements must be considered to understand what we will face as we begin the journey
to the next stage of personalized medicine—genetic therapy
and genomically targeted therapies for diseases.
10:45 a.m.–Noon
Concurrent Session I
Pompeian Ballroom/Promenade Level
What’s in Store for the Affordable Care Act…and You?
Moderator:
F Mary-Lou A. Misrahy, ARM, President and Chief Executive Officer,
Physicians Insurance A Mutual Company
Panel:
F Seth J. Chandler, JD, Foundation Professor of Law, Director,
Health Law & Policy Institute, University of Houston Law Center
F Ardis D. Hoven, MD, Immediate Past President, American Medical Association
Quite possibly the most controversial pieces of legislation
enacted by Congress in a generation, more than five years
after it was signed into law, the Affordable Care Act is still a
topic of fervid discussion. As its implementation continues, it is
important to know not only what its provisions do now, but also
what the future holds as more elements come into play. The
speakers will provide insights, from both pro and con perspectives, on what the ACA has done, what it will do, and what is
likely to happen as it becomes more fully integrated into the
U.S. healthcare system.
Noon–1:30 p.m.
Gold Sponsor Luncheon
sive medicine is, at once, both indefensible and entirely understandable. Until we confront and resolve the issues it presents,
American healthcare will not be able to fulfill its potential, as a
cost-effective and efficient system of quality care.
1:30–2:45 p.m.
Concurrent Session II
Roman Ballroom/Promenade Level
Simulation Is Safety: Perspectives from Aerospace, Human
Factors, and Healthcare
Moderator:
F Cathy M. Treen, Vice President, IU Health Risk Retention
Group, Inc.
Panel:
F Louis P. Halamek, MD, Professor of Pediatrics, Stanford University
F Michael R. Sterling, SGT, Inc. Training Quality and Standards
Group Spaceflight Training Management Office, Flight Operations Directorate NASA/JSC
F Luke Sato, MD, Senior Vice President, Chief Medical
Officer, CRICO
The use of simulation as a learning technique is becoming
increasingly popular in healthcare. Unfortunately, most of the
current efforts in healthcare simulation are targeted to relatively inexperienced professionals (like students and residents)
and are not linked to real-world outcomes. This panel brings
together experts who have extensive experience in healthcare,
human factors engineering, and the aerospace industry to
consider what simulation is, what it can accomplish, and how
best to develop and make the best use of a simulation-based
learning and assessment program that can directly addresses
the areas of known risk for your institution. Panelists will also
relate how simulation can be used to re-create near-misses and
adverse events, for subsequent detailed root cause analysis.
Augustus Ballroom I & II/Emperors Level
1:30–2:45 p.m.
Defensive Medicine and Healthcare Transformation in the
United States
Pompeian Ballroom/Promenade Level
F
Richard E. Anderson, MD, FACP, Chairman and Chief Executive
Officer, The Doctors Company
The insidious influence of defensive medicine affects medical
decision-making at virtually every level of care. Use of defen-
Concurrent Session II
Hard Lessons Learned with Systemic Risk: Defense and
Plaintiff Counsel Perspectives
Moderator:
F Robert M. Jones, President and Chief Executive Officer, Medical
Assurance Company of Mississippi
5
Panel:
F Thomas J. Donnelly, Esq., Donnelly Nelson Depolo & Murray
F Scott J. Eldredge, Esq., Burg Simpson
This session will address the issue of systemic risk, and the sorts
of strategies and new theories of liability that plaintiff’s attorneys may use to prevail in these cases. Plaintiff’s counsel may
attempt to insert new elements in the case beyond the mere
facts in evidence, and deploy the “Reptilian Theory” in their
attempt to persuade juries. The presenters will explain how
attendees can best counter these strategies, and also what they
can do to mitigate the frequency of these kinds of claims, which
can cause major financial damage to providers and healthcare
systems, in the future. They will also hear about what a company’s claims staff may expect from the defense attorneys who
are working on systemic risk claims.
2:45–3:15 p.m.
Refreshment Break in Exhibit Area
3:15–4:30 p.m.
Concurrent Session III
Roman Ballroom/Promenade Level
Patient Safety Organizations: Today’s Landscape and Tomorrow’s Implications
Moderator:
F Joseph S. Wilson, MD, Chairman and Chief Executive
Officer, MAG Mutual Insurance Company
Panel:
F Scott D. Geromette, Esq., Partner, Honigman Miller Schwartz
and Cohn LLP
F Cathy Pusey, RN, Manager, Clinical Analysis, ECRI Institute PSO
F D. Scott Jones, CHC, Senior Vice President, Risk Management and
Healthcare Compliance, Healthcare Providers Insurance Exchange
Patient Safety Organizations (PSOs) provide a vehicle for accelerating improvements in patient safety that, in turn, can
decrease adverse events and thus claims and suits. They do
so by allowing secure sharing and aggregation of information
on serious safety events and near misses, and the responses
to them, under federal guarantees of privilege so long as they
are retained within a defined Patient Safety Evaluation System
(PSES). These guarantees are intended to preempt most state
exceptions to such privilege. Nevertheless, we are seeing challenges to PSO rules from plaintiffs’ attorneys, and other parties,
in multiple venues. There also are complex federal rules for developing an institutional PSES and the privileged Patient Safety
Work Products (PSWP) within them that, if violated, can void
that privilege. The speakers in this session will address some
of the complexities of PSOs, PSESs, and PSWP’s and other aspects of the federal rules that are relatively unknown. They will,
in addition, discuss how PSOs can contribute substantially to
patient safety, when properly managed, and will illustrate these
contributions with specific examples.
3:15–4:30 p.m.
Concurrent Session III
Pompeian Ballroom/Promenade Level
They Just Won’t Quit: Attacks on Civil Justice Reform
Moderator:
F W. Stancil Starnes, JD, Chairman, President & Chief
Executive Officer, ProAssurance Corporation
Panel:
F Katherine H. Crocker, Esq.
F Jim DeBoo, Principal, DeBoo Communications
F Christine
Tomkins, MD, Chief Executive, The Medical
Defence Union
Experts with personal experience in advocating for civil justice
reform and protecting existing reforms will discuss the attacks
on both current and proposed medical liability reform laws.
They will relate the strategies that MPL carriers need to deploy
to defeat these attacks. A speaker from the U.K. will discuss
the push for litigation reform in that country and the challenges
faced internationally in promoting fairness and equity in medical
liability jurisprudence. Other presenters will focus on challenges
in the U.S., where the personal injury bar has been relentless in
its campaign to overturn state tort reforms, even in instances
where these reforms have been considered “settled law.” This
session also will feature specific lessons learned from California’s Proposition 46 debate, how opponents used unrelated
issues in trying to undermine the nearly 40-year-old MICRA law,
and how the 24/7 news cycle and social media played a major
role in both the defense of, and opposition to, MICRA.
4:30–6:00 p.m.
Platinum Sponsor Reception
Palace Ballroom Foyer/Emperors Level
Registered Attendees and Paid Guests Welcome
6
Friday, May 15, 2015
7:00–9:00 a.m.
in Exhibit Area
Silver Sponsor Breakfast
of the particular parameters they should be watching closely in
anticipation of the eventual hardening market.
10:15–10:45 a.m.
Refreshment Break in Exhibit Area
General Session
Florentine Ballroom/Emperors Level
10:45 a.m.–Noon
Registered Attendees and Paid Guests Welcome
Roman Ballroom/Emperors Level
8:00–9:00 a.m.
Big Data’s Big Impact on Healthcare and the MPL Industry
Annual Meeting of Members
Roman Ballroom/Emperors Level
F Gloria
H. Everett, Chair, PIAA
F Brian K. Atchinson, President & CEO, PIAA
This session is the annual business meeting of the PIAA membership. It includes the following agenda items: the election of
directors; reports from the Chair, President, and Treasurer; any
bylaws modifications deemed necessary and any other business
that needs to come before the PIAA membership; and a discussion of the PIAA’s governance and business activities. All PIAA
members are encouraged to attend.
9:00–9:15 a.m. PIAA Award of Excellence in
Public Policy and Advocacy
Roman Ballroom/Emperors Level
2015 PIAA Award of Excellence in
Public Policy and Advocacy
Dustin Corcoran
Chief Executive
Officer,
California Medical Association
Jim DeBoo
Principal,
DeBoo
Communications
Lisa Maas
Executive Director,
Californians
Allied for Patient
Protection
Moderator:
F Michelle Hoppes, RN, AHRMQR, DFASHRM, President, Michigan Professional Insurance Exchange
Panel:
F Raju Bohra, Executive Vice President, Willis Re Analytics
F Mark E. Dorn, President & CEO, DAVID Corporation
F David P. Duden, Director, Deloitte Consulting
F Chad C. Karls, FCAS, MAAA, Principal & Consulting Actuary,
Milliman, Inc.
There is a data revolution occurring and “Big Data” is a hot
topic. Many companies consider data generation and collection
as mission critical. Industries are recognizing the need to convert data into knowledge and knowledge into intelligence. In
this session, attendees will learn about the analytics imperative,
the process for real time operational intelligence to drive key
performance indicators, and methods to predict and monitor
outcomes and results. There will be a focus on new sources of
data for making decisions in underwriting, rating, and pricing
that may expand the strategic capacity of liability companies.
Learning how to selectively identify and apply this data accurately for risk control and underwriting can have a positive
impact on an MPL program’s profitability. Big data can also
be combined with scoring algorithms and other data analytic
tools, to further advance the science of underwriting and risk
management. The speakers will also discuss the potential uses
of predictive exposure data and how using data coding taxonomies can leverage the value of big data.
Noon–2:00 p.m.
Gold Sponsor Luncheon
Roman Ballroom/Emperors Level
Here Come the Millennials: Physicians,
Patients, and Presumptions
9:15–10:15 a.m.
General Session
Roman Ballroom/Emperors Level
MPL Insurance Industry Performance: What’s the Latest?
F Chad
C. Karls, FCAS, MAAA, Principal & Consulting
Actuary, Milliman, Inc.
Mr. Karls will brief attendees on the essential historical, and
current, financial results of the MPL industry, highlighting the
primary drivers behind the industry’s improved capital position. He will also comment on the several factors now in play
that may well culminate in an emerging hard market. Armed
with a better understanding of the underlying drivers of the
industry’s current financial condition, attendees will be aware
F Scott Hess, Senior Vice President,
Human Intelligence, Spark
Scott Hess
Millennials comprise the biggest living generation, some 80 million strong. Learn more about what to expect
from them—and how to connect with them as colleagues and
clients—from someone who’s spent the past 15 years studying
them. Noted Millennial expert Scott Hess will take us inside
their minds and hearts, to explore their attitudes, values, beliefs, and behaviors, and explain why they matter.
2:00 p.m.
Adjourn
7
8